...
首页> 外文期刊>Pharmaceutical sciences. >RNA-Interference-Mediated Silencing of OCT4B1, Alters Expression Profile of Several TNF Ligand/ Receptor Transcripts in Human Tumor Cell Lines
【24h】

RNA-Interference-Mediated Silencing of OCT4B1, Alters Expression Profile of Several TNF Ligand/ Receptor Transcripts in Human Tumor Cell Lines

机译:RNA干扰介导的OCT4B1沉默,改变人类肿瘤细胞系中几个TNF配体/受体转录物的表达谱。

获取原文

摘要

Background: The OCT4B1 as a new discovered variant of OCT4 is expressed in both cancer cell and tissues. This variant with its anti-apoptotic properties aid cancer cells to scape from apoptosis. TNF ligands and receptors are amongst two categories of eleven gene families involved in the apoptosis pathway. Therefore, the aim of the present study was to investigate the effects of OCT4B1 suppression on several transcripts of both TNF ligands and receptors family in some tumor cell lines. Methods: The AGS (gastric adenocarcinoma), 5637 (bladder tumor) and U-87MG (brain tumor) tumor cell lines were transfected with specific OCT4B1 siRNA and , as well as a scrambled sequence and PBS, as controls, using Lipofectamine 2000 comerical kit. The expression of TNF ligand and receptor transcripts were evaluated in parallel with beta-actin (as housekeeping gene) using Real-Time PCR technique. Results: our results indicated that in TNF ligand transcripts family, the mRNA level of TNF transcripts was up-regulated and inversely TNFSF8, TNFSF7, TNFSF10, TNFSF1 and TNFSF6 was down-regulated. We observed also that in TNF receptor transcripts family, six transcripts including, TNFRSF 10A, TNFRSF10B, TNFRSF11B, TNFRSF1A, TNFRSF21 and TNFRSF25 were up-regulated, while TNFRSF9 and CD27 were down-regulated. Conclusions: According to these results, it may be concluded that OCT4B1 suppression can lead to apoptosis in tumor cell lines via up-regulation of several TNF ligand and receptor transcripts. Thus, OCT4B1 suppression effects on TNF and its receptors may be considered as promising target genes in future studies in cancr research and therapy.
机译:背景:作为新发现的OCT4变体,OCT4B1在癌细胞和组织中均表达。这种具有抗凋亡特性的变体可以帮助癌细胞摆脱凋亡。 TNF配体和受体是参与凋亡途径的11个基因家族的两大类。因此,本研究的目的是研究OCT4B1抑制对某些肿瘤细胞系中TNF配体和受体家族的几种转录本的影响。方法:使用Lipofectamine 2000试剂盒,以特异的OCT4B1 siRNA转染AGS(胃腺癌),5637(膀胱肿瘤)和U-87MG(脑肿瘤)肿瘤细胞系,并以加扰序列和PBS为对照。 。使用实时PCR技术,与β-肌动蛋白(作为管家基因)并行评估TNF配体和受体转录物的表达。结果:我们的结果表明,在TNF配体转录物家族中,TNF转录物的mRNA水平上调,而TNFSF8,TNFSF7,TNFSF10,TNFSF1和TNFSF6相反。我们还观察到,在TNF受体转录物家族中,包括TNFRSF 10A,TNFRSF10B,TNFRSF11B,TNFRSF1A,TNFRSF21和TNFRSF25在内的六种转录物被上调,而TNFRSF9和CD27被下调。结论:根据这些结果,可以得出结论,OCT4B1抑制可通过上调几种TNF配体和受体转录物而导致肿瘤细胞凋亡。因此,OCT4B1对TNF及其受体的抑制作用可能被认为是未来癌症研究和治疗中的有希望的靶基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号